Insider’s View: Deciphering Solid Biosciences Inc (SLDB)’s Financial Health Through Ratios

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

The price of Solid Biosciences Inc (NASDAQ: SLDB) closed at $6.47 in the last session, up 22.08% from day before closing price of $5.30. In other words, the price has increased by $22.08 from its previous closing price. On the day, 15.19 million shares were traded.

Ratios:

We take a closer look at SLDB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.85 and its Current Ratio is at 7.85. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.13.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 08, 2025, initiated with a Buy rating and assigned the stock a target price of $16.

On December 13, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $16.

On December 10, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $15.JMP Securities initiated its Mkt Outperform rating on December 10, 2024, with a $15 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when Adage Capital Management, L.P. bought 252,545 shares for $7.56 per share. The transaction valued at 1,909,240 led to the insider holds 4,248,084 shares of the business.

Hanrahan Jessie sold 3,079 shares of SLDB for $12,193 on Feb 14 ’25. The Chief Regulatory Officer now owns 19,281 shares after completing the transaction at $3.96 per share. On Feb 14 ’25, another insider, Brooks Gabriel, who serves as the Chief Medical Officer of the company, sold 3,256 shares for $3.96 each. As a result, the insider received 12,894 and left with 22,812 shares of the company.

Stock Price History:

Over the past 52 weeks, SLDB has reached a high of $15.05, while it has fallen to a 52-week low of $2.88. The 50-Day Moving Average of the stock is 65.97%, while the 200-Day Moving Average is calculated to be -1.40%.

Shares Statistics:

A total of 38.93M shares are outstanding, with a floating share count of 31.74M. Insiders hold about 20.56% of the company’s shares, while institutions hold 71.59% stake in the company.

Most Popular